Optimizing Delivery of Diabetes Management During Breast Cancer Care

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving cancer treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Newly diagnosed invasive cancer

• Plan to receive neo-adjuvant or adjuvant chemotherapy, targeted therapy, hormonal therapy, or radiation at Weill Cornell Medicine (WCM)

‣ Age 18+ years

⁃ Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR

• HbA1c greater than or equal to 5.7 OR

• Random glucose greater than or equal to OR

• Fasting blood glucose greater than or equal to 100

Locations
United States
New York
NewYork-Presbyterian Brooklyn Methodist Hospital
RECRUITING
Brooklyn
New York-Presbyterian Queens
RECRUITING
Flushing
Weill Cornell Medicine
RECRUITING
New York
Contact Information
Primary
Laura C Pinheiro, PhD, MPH
lcp2003@med.cornell.edu
646-962-5898
Backup
Katherine Berg, MPH
kab7065@med.cornell.edu
646-962-5038
Time Frame
Start Date: 2023-02-28
Estimated Completion Date: 2026-12
Participants
Target number of participants: 76
Treatments
Experimental: Nurse-practitioner led intervention group
A nurse practitioner (NP) who is trained in diabetes on the oncology team will help manage diabetes for breast cancer patients undergoing cancer treatments
No_intervention: Non-intervention (control) group
Patient will not have access to the nurse practitioner led intervention.
Related Therapeutic Areas
Sponsors
Leads: Weill Medical College of Cornell University
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov